en
Scientific article
English

Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments

Published inPharmacogenetics and genomics, vol. 25, no. 5, p. 246-258
Publication date2015
Abstract

Metabolic syndrome (MetS) associated with psychiatric disorders and psychotropic treatments represents a major health issue. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) is an enzyme that catalyzes tissue regeneration of active cortisol from cortisone. Elevated enzymatic activity of 11β-HSD1 may lead to the development of MetS.

Citation (ISO format)
QUTEINEH, Lina et al. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. In: Pharmacogenetics and genomics, 2015, vol. 25, n° 5, p. 246–258. doi: 10.1097/FPC.0000000000000131
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1744-6872
541views
0downloads

Technical informations

Creation10/13/2015 11:19:00 AM
First validation10/13/2015 11:19:00 AM
Update time03/14/2023 11:59:23 PM
Status update03/14/2023 11:59:22 PM
Last indexation01/16/2024 7:51:37 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack